Fibrocartilaginous embolism (FCE), also known as fibrocartilaginous embolic myelopathy (FCEM), is an acute, non-compressive vascular disorder of the spinal cord caused by embolization of spinal vasculature with fibrocartilaginous material...
Overview and Clinical Importance
Fibrocartilaginous embolism (FCE), also known as fibrocartilaginous embolic myelopathy (FCEM), is an acute, non-compressive vascular disorder of the spinal cord caused by embolization of spinal vasculature with fibrocartilaginous material histologically identical to the nucleus pulposus of the intervertebral disc. FCE causes ischemic necrosis of dependent spinal cord regions, resulting in sudden-onset neurological deficits. While more commonly documented in dogs, FCE is an important differential diagnosis in cats presenting with peracute myelopathy and represents a high-yield topic for NAVLE examination.
Unlike compressive intervertebral disc disease, FCE is a non-surgical condition requiring conservative management with physical rehabilitation. The pathophysiology involves acute ischemic injury similar to a "spinal stroke," making early recognition and differentiation from other causes of acute myelopathy essential for appropriate patient management.
| Vessel |
Territory Supplied |
Clinical Significance |
| Anterior Spinal Artery (ASA) |
Ventral 2/3 of spinal cord including ventral horns, lateral columns, and corticospinal tracts |
Most commonly affected in FCE; ASA narrowest at C2 in cats |
| Posterior Spinal Arteries (paired) |
Dorsal 1/3 of spinal cord including dorsal columns and dorsal horns |
Less commonly affected; proprioception preserved if posterior columns spared |
| Radicular Arteries |
Segmental supply reinforcing longitudinal vessels |
Provide collateral circulation; fewer in thoracic region (watershed area) |
Etiology and Pathophysiology
Source of Embolic Material
The embolic material in FCE is histochemically identical to nucleus pulposus of the intervertebral disc. The nucleus pulposus is the gel-like center of the intervertebral disc, composed of fibrocartilaginous material rich in proteoglycans. The exact mechanism by which this material enters the spinal vasculature remains incompletely understood, but several theories have been proposed:
- Direct vascular entry: Disc material may enter vertebral body venous sinusoids or arterial vessels during mechanical stress
- Anomalous vasculature: Persistent embryonic vessels within the annulus fibrosus may provide a route for embolic material
- Chronic inflammation: Neovascularization from chronic disc degeneration may create abnormal vascular connections
- Arteriovenous anastomoses: Retrograde flow through vertebral venous plexus may deliver emboli to arterial circulation
Mechanism of Spinal Cord Injury
When fibrocartilaginous material embolizes to spinal cord vasculature, it causes acute ischemic infarction of the dependent spinal cord parenchyma. The spinal cord receives blood supply from three main longitudinal vessels:
High-YieldIn cats, the ventral spinal artery (VSA) is narrowest at the C2 vertebral level, making the cervical spinal cord particularly susceptible to FCE. This anatomical predisposition explains why cervical lesions (C1-C5) are more common in cats compared to dogs, where thoracolumbar FCE predominates.
| Parameter |
Feline FCE Characteristics |
| Age |
Middle-aged to older cats; median age 10 years (range 6 months to 17 years); most cats older than 7 years |
| Breed |
Domestic Shorthair most commonly represented; no strong breed predisposition identified |
| Sex |
No consistent sex predilection documented in cats |
| Common Lesion Location |
Cervicothoracic intumescence (C6-T2) most common (50%), followed by cervical (C1-C5) and lumbosacral regions |
| Concurrent Conditions |
Older cats may have underlying conditions: hypertension, cardiac disease, hyperthyroidism, chronic kidney disease |
Signalment and Epidemiology
Feline-Specific Characteristics
NAVLE TipUnlike dogs where large and giant breed young to middle-aged dogs predominate, feline FCE typically affects older cats (median 10 years) and often occurs in cats with underlying systemic conditions. Always perform thorough diagnostics including T4, blood pressure, and cardiac evaluation in cats with suspected FCE.
| Feature |
Description |
| Peracute Onset |
Clinical signs develop within minutes to hours (less than 6 hours); often during or immediately following physical activity |
| Painless (after 24h) |
Initial yelp or vocalization may occur at onset; spinal hyperesthesia typically absent or resolves within 24-48 hours |
| Plateau (Non-progressive) |
Neurological deficits stabilize within 24-48 hours and do not progress thereafter; progression beyond this period suggests alternative diagnosis |
| Asymmetric Paresis |
Often lateralized with one side more severely affected; reflects asymmetric vascular distribution of emboli |
Clinical Presentation
Hallmark Features
The clinical presentation of FCE is characterized by the "4 Ps" that help differentiate it from other causes of acute myelopathy:
Memory Aid - "SNAP": Sudden onset, Non-painful, Asymmetric, Plateau (non-progressive). If a cat presents with all four features, FCE should be high on your differential list.
Neurological Examination Findings
Clinical signs depend on the location and extent of spinal cord ischemia:
Cervical Lesions (C1-C5)
- Tetraparesis or tetraplegia (often asymmetric)
- Upper motor neuron (UMN) signs to all four limbs
- Normal to exaggerated spinal reflexes
- Possible respiratory compromise with high cervical lesions
- Cervical ventroflexion reported in some cases
Cervicothoracic Lesions (C6-T2)
- Lower motor neuron (LMN) signs to thoracic limbs
- UMN signs to pelvic limbs
- Reduced or absent thoracic limb withdrawal reflexes
- Possible Horner syndrome (ipsilateral miosis, ptosis, enophthalmos, third eyelid protrusion)
Thoracolumbar Lesions (T3-L3)
- Paraparesis or paraplegia
- UMN signs to pelvic limbs
- Normal thoracic limb function
- Possible Schiff-Sherrington posture (thoracic limb extensor rigidity)
Lumbosacral Lesions (L4-S3)
- LMN signs to pelvic limbs
- Reduced or absent patellar and withdrawal reflexes
- Flaccid tail, urinary and fecal incontinence
- Decreased anal tone
| Diagnostic Test |
Findings and Clinical Utility |
| Complete Blood Count |
Usually unremarkable; rule out infectious/inflammatory causes |
| Serum Biochemistry |
Usually unremarkable; creatine kinase may be mildly elevated |
| T4 Level (cats) |
Screen for hyperthyroidism as predisposing condition |
| Blood Pressure |
Evaluate for systemic hypertension |
| Cardiac Ultrasound |
Rule out cardiomyopathy as source of thromboemboli |
| Spinal Radiographs |
Usually normal; rule out vertebral fractures, discospondylitis, or obvious disc disease |
| MRI (Gold Standard) |
Best imaging modality; reveals characteristic intramedullary lesion pattern |
| CSF Analysis |
Often normal or mild non-specific changes (xanthochromia, elevated protein, mild pleocytosis) |
Diagnosis
Definitive diagnosis of FCE requires histopathological examination demonstrating fibrocartilaginous material within spinal cord vasculature with toluidine blue metachromatic staining. However, presumptive antemortem diagnosis is based on characteristic clinical presentation combined with MRI findings and exclusion of other etiologies.
Diagnostic Workup
MRI Findings
MRI is the imaging modality of choice for diagnosing FCE and differentiating it from compressive myelopathies. Characteristic MRI features include:
High-YieldOn NAVLE, remember that FCE produces an INTRAMEDULLARY (within the spinal cord parenchyma) lesion that is hyperintense on T2-weighted images, located OVER a vertebral body (not the disc space), and shows NO extradural compression. This pattern helps differentiate FCE from acute disc extrusion, which shows extradural compression centered over the disc space.
| MRI Sequence |
FCE Appearance |
| T2-Weighted |
Hyperintense, well-demarcated, focal intramedullary lesion; often lateralized |
| T1-Weighted |
Iso- to hypointense relative to normal gray matter |
| FLAIR |
Hyperintense lesion (similar to T2-weighted) |
| Post-Contrast |
Usually no enhancement acutely; may enhance 5-7 days post-onset |
| Lesion Location |
Typically over vertebral body (NOT over intervertebral disc space); ventral gray matter predominance |
| Key Differentiating Feature |
No extradural compression; no disc herniation; sharply demarcated lesion margins |
Differential Diagnosis
The differential diagnosis for acute-onset myelopathy in cats includes:
NAVLE TipThe key differentiator between FCE and aortic thromboembolism (ATE) is PAIN and peripheral pulses. ATE is extremely painful with absent femoral pulses, cold limbs, and firm gastrocnemius muscles. FCE is non-painful (after initial onset) with normal peripheral pulses and limb temperature. Both cause acute pelvic limb paralysis!
| Condition |
Key Features |
Differentiating Factors |
| Aortic Thromboembolism (ATE) |
Acute pelvic limb paralysis; cold, pulseless limbs; severe pain |
Painful; absent femoral pulses; firm gastrocnemius; cardiac disease history |
| Intervertebral Disc Extrusion (IVDE) |
Acute paresis; often painful; may be compressive |
Spinal hyperesthesia; extradural compression on MRI; disc changes visible |
| Acute Non-Compressive Nucleus Pulposus Extrusion (ANNPE) |
Peracute onset; often trauma-associated; non-progressive |
Lesion over disc space (not vertebral body); narrowed disc space; epidural signal changes |
| Vertebral Fracture/Luxation |
Acute paresis; trauma history; severe pain |
Bony abnormalities on radiographs/CT; history of trauma |
| Spinal Lymphoma |
Progressive myelopathy; may be peracute if hemorrhage occurs |
Usually progressive; enhancing mass on MRI; FeLV/FIV status |
| FIP Myelitis |
Progressive; may have multifocal signs; systemic illness |
Progressive course; CSF changes; hyperglobulinemia; young cats |
Treatment
FCE is a non-surgical condition. Unlike compressive disc disease, there is no role for decompressive surgery because the spinal cord injury results from ischemia/infarction, not compression. Treatment is conservative and supportive.
Conservative Management
High-YieldPhysical therapy is the ONLY treatment proven to speed recovery from FCE. Steroids (including MPSS protocols) have NOT been shown to improve outcomes and are not recommended. On NAVLE, if asked about treatment for FCE, physical rehabilitation is the correct answer - NOT surgery, NOT steroids.
| Treatment Component |
Details |
| Physical Therapy |
GOLD STANDARD treatment; passive range of motion, massage, assisted standing/walking, neuromuscular stimulation, hydrotherapy (underwater treadmill) |
| Nursing Care |
Padded bedding, turning every 4-6 hours to prevent decubital ulcers, clean and dry environment |
| Bladder Management |
Manual bladder expression 3-4 times daily if urinary retention; monitor for UTI; consider indwelling urinary catheter if needed |
| Analgesia (if needed) |
NSAIDs if spinal hyperesthesia present in first 24-48 hours; gabapentin for neuropathic pain |
| Steroids |
NO proven benefit; high-dose steroids (including methylprednisolone sodium succinate) have NOT been shown to improve outcomes |
| Mobility Aids |
Slings, harnesses, carts (wheelchairs) for mobility support during recovery |
| Address Underlying Conditions |
Treat hypertension, hyperthyroidism, cardiac disease if present; may reduce risk of recurrence |
Prognosis
Prognosis for FCE is variable and depends on several factors:
Prognostic Factors
Expected Outcomes
- Recovery rate: Approximately 79% of cats recover the ability to walk
- Timeline: Most improvement occurs within 2-6 weeks; maximum recovery typically by 6-8 weeks
- Plateau: Recovery often reaches a plateau; some residual deficits may persist
- Recurrence: Extremely rare; second FCE unlikely
- Continence: Some cats may have persistent urinary or fecal incontinence
Memory Aid - "DIP" for Prognosis: Deep pain perception (most important), Initial severity, and Prompt improvement within 2 weeks are the key prognostic indicators. If a cat has intact deep pain and shows improvement within 2 weeks, prognosis is favorable!
| Factor |
Good Prognosis |
Poor Prognosis |
| Deep Pain Perception |
Present (intact nociception) |
Absent (loss of nociception) |
| Severity at Presentation |
Ambulatory paresis; mild deficits |
Plegia; severe/complete paralysis |
| MRI Lesion Size |
Smaller lesion extent |
Larger/extensive lesion |
| Early Improvement |
Improvement within 2 weeks |
No improvement by 3 weeks |
| Lesion Location |
Spinal cord only |
Brain involvement (rare) |